Localization and upregulation of survivin in cancer health disparities: a clinical perspective
Salma Khan,1,2 Heather Ferguson Bennit,1,2 Malyn May Asuncion Valenzuela,1,2 David Turay,1,3 Carlos J Diaz Osterman,1,2 Ron B Moyron,1,2 Grace E Esebanmen,1,2 Arjun Ashok,1,2 Nathan R Wall1,2 1Department of Biochemistry, 2Center for Health Disparities and Molecular Medicine, 3Department of Anatomy,...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e50eb269141f4d299d10cae8a1a3ab41 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e50eb269141f4d299d10cae8a1a3ab41 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e50eb269141f4d299d10cae8a1a3ab412021-12-02T05:49:16ZLocalization and upregulation of survivin in cancer health disparities: a clinical perspective1177-5491https://doaj.org/article/e50eb269141f4d299d10cae8a1a3ab412015-07-01T00:00:00Zhttp://www.dovepress.com/localization-and-upregulation-of-survivin-in-cancer-health-disparities-peer-reviewed-article-BTThttps://doaj.org/toc/1177-5491Salma Khan,1,2 Heather Ferguson Bennit,1,2 Malyn May Asuncion Valenzuela,1,2 David Turay,1,3 Carlos J Diaz Osterman,1,2 Ron B Moyron,1,2 Grace E Esebanmen,1,2 Arjun Ashok,1,2 Nathan R Wall1,2 1Department of Biochemistry, 2Center for Health Disparities and Molecular Medicine, 3Department of Anatomy, Loma Linda University School of Medicine, Loma Linda, CA, USA Abstract: Survivin is one of the most important members of the inhibitors of apoptosis protein family, as it is expressed in most human cancers but is absent in normal, differentiated tissues. Lending to its importance, survivin has proven associations with apoptosis and cell cycle control, and has more recently been shown to modulate the tumor microenvironment and immune evasion as a result of its extracellular localization. Upregulation of survivin has been found in many cancers including breast, prostate, pancreatic, and hematological malignancies, and it may prove to be associated with the advanced presentation, poorer prognosis, and lower survival rates observed in ethnically diverse populations. Keywords: survivin, cancer, exosomes, health disparityKhan SFerguson Bennit HAsuncion Valenzuela MMTuray DDiaz Osterman CJMoyron RBEsebanmen GEAshok AWall NRDove Medical PressarticleMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol 2015, Iss default, Pp 57-67 (2015) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine (General) R5-920 |
spellingShingle |
Medicine (General) R5-920 Khan S Ferguson Bennit H Asuncion Valenzuela MM Turay D Diaz Osterman CJ Moyron RB Esebanmen GE Ashok A Wall NR Localization and upregulation of survivin in cancer health disparities: a clinical perspective |
description |
Salma Khan,1,2 Heather Ferguson Bennit,1,2 Malyn May Asuncion Valenzuela,1,2 David Turay,1,3 Carlos J Diaz Osterman,1,2 Ron B Moyron,1,2 Grace E Esebanmen,1,2 Arjun Ashok,1,2 Nathan R Wall1,2 1Department of Biochemistry, 2Center for Health Disparities and Molecular Medicine, 3Department of Anatomy, Loma Linda University School of Medicine, Loma Linda, CA, USA Abstract: Survivin is one of the most important members of the inhibitors of apoptosis protein family, as it is expressed in most human cancers but is absent in normal, differentiated tissues. Lending to its importance, survivin has proven associations with apoptosis and cell cycle control, and has more recently been shown to modulate the tumor microenvironment and immune evasion as a result of its extracellular localization. Upregulation of survivin has been found in many cancers including breast, prostate, pancreatic, and hematological malignancies, and it may prove to be associated with the advanced presentation, poorer prognosis, and lower survival rates observed in ethnically diverse populations. Keywords: survivin, cancer, exosomes, health disparity |
format |
article |
author |
Khan S Ferguson Bennit H Asuncion Valenzuela MM Turay D Diaz Osterman CJ Moyron RB Esebanmen GE Ashok A Wall NR |
author_facet |
Khan S Ferguson Bennit H Asuncion Valenzuela MM Turay D Diaz Osterman CJ Moyron RB Esebanmen GE Ashok A Wall NR |
author_sort |
Khan S |
title |
Localization and upregulation of survivin in cancer health disparities: a clinical perspective |
title_short |
Localization and upregulation of survivin in cancer health disparities: a clinical perspective |
title_full |
Localization and upregulation of survivin in cancer health disparities: a clinical perspective |
title_fullStr |
Localization and upregulation of survivin in cancer health disparities: a clinical perspective |
title_full_unstemmed |
Localization and upregulation of survivin in cancer health disparities: a clinical perspective |
title_sort |
localization and upregulation of survivin in cancer health disparities: a clinical perspective |
publisher |
Dove Medical Press |
publishDate |
2015 |
url |
https://doaj.org/article/e50eb269141f4d299d10cae8a1a3ab41 |
work_keys_str_mv |
AT khans localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective AT fergusonbennith localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective AT asuncionvalenzuelamm localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective AT turayd localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective AT diazostermancj localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective AT moyronrb localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective AT esebanmenge localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective AT ashoka localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective AT wallnr localizationandupregulationofsurvivinincancerhealthdisparitiesaclinicalperspective |
_version_ |
1718400265398255616 |